Patellar Metastasis as the First Manifestation of an Adenocarcinoma of the Lung

CHEST Journal ◽  
2014 ◽  
Vol 145 (3) ◽  
pp. 316A
Author(s):  
Marta Sousa ◽  
Vitor Melo ◽  
Eloisa Silva ◽  
Jorge Vale ◽  
João Silva ◽  
...  
Keyword(s):  
Adenocarcinoma Of The Lung

A Case of Adenocarcinoma of the Lung Associated with Dermatomyositis in a 36 Year-Old Man.

Haigan ◽  
1997 ◽  
Vol 37 (1) ◽  
pp. 87-91
Author(s):  
Masanori Sakurai ◽  
Makoto Nishio ◽  
Atuya Karato ◽  
Izumi Hayashi ◽  
Takahiro Watanabe ◽  
...  
Keyword(s):  
Adenocarcinoma Of The Lung

scholarly journals Erythema Gyratum Repens in Long-Term Smoker

2019 ◽  
Vol 11 (3) ◽  
pp. 268-272
Author(s):  
Andrew P. Sauvageau ◽  
Jacob Mojeski ◽  
Thomas W. Fiorica ◽  
Craig C. Miller
Keyword(s):  
Female Patient ◽  
Skin Condition ◽  
Morbidity And Mortality ◽  
Cancer Growth ◽  
Internal Malignancy ◽  
Adenocarcinoma Of The Lung

Erythema gyratum repens (EGR) is a rare paraneoplastic skin condition characterized by the eruption of expanding, concentric, erythematous patches and plaques. The condition may precede a symptomatic appearance of internal malignancy, and therefore provides a unique opportunity to prevent additional morbidity and mortality secondary to undetectable cancer growth. We report the case of a 71-year-old female patient clinically diagnosed with EGR and subsequently diagnosed with otherwise asymptomatic adenocarcinoma of the lung.

A case of double primary adenocarcinoma of the lung with multiple atypical adenomatous hyperplasia

1998 ◽  
Vol 48 (8) ◽  
pp. 634-640 ◽  
Author(s):  
Yoichi Anami ◽  
Yoshihiro Matsuno ◽  
Tesshi Yamada ◽  
Tomoyo Takeuchi ◽  
Haruhiko Nakayama ◽  
...  
Keyword(s):  
Primary Adenocarcinoma ◽  
Atypical Adenomatous Hyperplasia ◽  
Adenomatous Hyperplasia ◽  
Adenocarcinoma Of The Lung

scholarly journals Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database

Open Medicine ◽  
2021 ◽  
Vol 16 (1) ◽  
pp. 169-174
Author(s):  
Lei Lei ◽  
Liu Yang ◽  
Yang-yang Xu ◽  
Hua-fei Chen ◽  
Ping Zhan ◽  
...  
Keyword(s):  
Prognostic Factors ◽  
Clinical Features ◽  
Survival Benefit ◽  
Stage Iv ◽  
Primary Lesion ◽  
Hepatoid Adenocarcinoma ◽  
Seer Database ◽  
Primary Tumor Size ◽  
Adenocarcinoma Of The Lung ◽  
To Receive

Abstract Hepatoid adenocarcinoma of the lung (HAL) is a rare malignant tumor that is defined as a primary alpha-fetoprotein (AFP)-producing lung carcinoma. We aimed to identify prognostic factors associated with the survival of patients with HAL using data from the Surveillance, Epidemiology, and End Results (SEER) database. We collected data from patients diagnosed with HAL, adenocarcinoma (ADC), and squamous cell carcinoma (SCC) of the lung between 1975 and 2016 from the SEER database. The clinical features of patients with ADC and SCC of the lung were also analyzed. The clinical features of HALs were compared to ADCs and SCCs. A chi-square test was used to calculate the correlations between categorical variables, and a t test or Mann–Whitney U test was used for continuous variables. The Kaplan–Meier method and Cox regression analysis were used to identify the prognostic factors for the overall survival (OS) of HALs. Two-tailed p values < 0.05 were considered statistically significant. Sixty-five patients with HAL, 2,84,379 patients with ADC, and 1,86,494 with SCC were identified from the SEER database. Fewer males, advanced stages, and more chemotherapy-treated HALs were found. Compared to patients with SCC, patients with HAL were less likely to be male, more likely to be in an advanced stage, and more likely to receive chemotherapy (p < 0.05). The American Joint Committee on Cancer staging was the only prognostic factor for OS in patients with HAL, and stage IV was significantly different from other stages (hazard ratio = 0.045, 95% confidence interval: 0.005–0.398, p = 0.005). Males with HAL were more likely to receive radiotherapy compared to females with HAL (61.8 vs 31.5%, p = 0.034). Younger patients with HAL were more likely to receive chemotherapy (59.4 + 10.2 years vs 69 + 11.3 years, p = 0.001). The primary tumor size of HAL was associated with the location of the primary lesion (p = 0.012). No conventional antitumor therapies, including surgery, chemotherapy, and radiotherapy, were shown to have a significant survival benefit in patients with HAL (p > 0.05). This study showed that stage IV was the only prognostic factor for OS in HALs compared to other clinicopathologic factors. Conventional antitumor therapies failed to show survival benefit; thus, a more effective method by which to treat HAL is needed. Interestingly, the clinical features and the location of the primary lesion were shown to be associated with primary tumor size and treatment in patients with HAL, which have not been reported before.

scholarly journals MUCOOELLULAR PAPILLARY ADENOCARCINOMA OF THE LUNG

1950 ◽  
Vol 19 (6) ◽  
pp. 875-876
Author(s):  
Kermit E. Osserman ◽  
Harold Neuhop
Keyword(s):  
Papillary Adenocarcinoma ◽  
Adenocarcinoma Of The Lung

scholarly journals Ret Translocation in Adenocarcinoma of the Lung

2014 ◽  
Vol 25 ◽  
pp. iv461
Author(s):  
S. Michels ◽  
A. Schultheis ◽  
M. Scheffler ◽  
T. Rosner ◽  
S. Merkelbach-Bruse ◽  
...  
Keyword(s):  
Adenocarcinoma Of The Lung

Hepatoid adenocarcinoma of the lung and the review of the literature

2020 ◽  
Vol 26 (6) ◽  
pp. 1505-1510
Author(s):  
Onder Tonyali ◽  
Onur Gonullu ◽  
Mehmet Akif Ozturk ◽  
Aysun Kosif ◽  
Ozlenen Gonca Civi
Keyword(s):  
Concurrent Chemoradiotherapy ◽  
Mediastinal Lymph Node ◽  
Alpha Fetoprotein ◽  
Disease Stage ◽  
Hepatoid Adenocarcinoma ◽  
Rare Type ◽  
Adenocarcinoma Of The Lung ◽  
Female Smoker ◽  
Diagnostic Biopsy ◽  
Serum Alpha Fetoprotein

Introduction Hepatoid adenocarcinoma of the lung is an extremely rare type of the non-small cell lung cancer. Treatment principles and prognosis are similar to that of lung adenocarcinoma. Case report A 62-year-old female smoker presented with a huge mass in the left upper lobe. After diagnostic biopsy, she underwent left pneumonectomy and mediastinal lymph node dissection. A diagnosis of stage T4N1M0 hepatoid adenocarcinoma of the lung with positive surgical margins was made. Management and outcome After the operation, the level of serum alpha fetoprotein was 9010 ng/ml (N: <10). The level of serum alpha fetoprotein was decreased with concurrent chemoradiotherapy and chemotherapy. Disease progression was detected at 11 months after diagnosis. No response was obtained to other therapies. The patient died at 14 months from the time of diagnosis. Discussion Usually, patients with hepatoid adenocarcinoma of the lung are male smokers. Hepatoid adenocarcinoma tends to settle in the upper lobes of the lung. The most important prognostic factor of the hepatoid adenocarcinoma of the lung is the disease stage at the diagnosis and patients with metastatic disease have poor survival.

Sign in / Sign up

Export Citation Format

Share Document